RE: Whole Genome Sequencing26 Feb 2021 11:57
@VanV, my agenda is simple I want this company to be bought out for say £30 a pop. I don’t have time to wait 2 or 3 years. Having said that my feeling is that this company has performed amazingly well and will be a good acquisition for the likes of AZN. I wonder if award of a super large contract would have any strings attached, e.g the company must be part of a UK company to retain the technology and the long term relationship being forged. BOJO may not want the money to flow out to France. I will defer to others to discuss the financials, not my bag. The potential to scale up and realise worldwide sales must be being eyed up by several multinationals. A buyout at a fair price would allow this to happen at a pace that GM and his team can’t achieve this. A larger organisation has established links with governments, the doors are already opened. If there is a scramble to acquire NCYT then the SP could well be close to Porky’s number. So we land DHSC 2 year deal worth a lot, on top of the surge testing already ringing up £££, Promate in France, sales in US, technology not restricted to COVID etc. What here makes anyone doubt the NCYT potential? Let us see what the next few weeks bring. BOJO has finally realised this thing COVID is not going away too easily and is proving to be a formidable foe. The scientists are coming, have come to the rescue.